Some physicians believe that peer review of expert witness testimony is essestial to keep the judicial system fair.
Some physicians believe that peer review of expert witness testimony is essential to keep the judicial system fair. Others believe that such programs are aimed at deterring doctors from testifying for plaintiffs and stopping valid claims. A recent Minnesota trial court ruling appeared to support the first view, according to an account in American Medical News (4/21/08) of an ophthalmologist's suit against two other opthalmologists, all members of the American Academy of Ophthalmology (AAO), as well as the academy itself.
A Hennepin County District Court judge tossed out claims that the AAO defamed Charles Yancy, MD, an AAO member, when the society's ethics committee examined Dr. Yancy's statements as a plaintiff expert in a medical liability case. The investigation followed a complaint made by the two other academy members, who accused Dr. Yancy of giving misleading testimony. The court said that as an AAO member, Dr. Yancy agreed to abide by the academy's ethical rules and regulations, which include a peer review system for questionable medical testimony. Though the judge dismissed Dr. Yancy's claims that the AAO and the two other academy members had conspired to intimidate him from testifying in future cases, it did allow Dr. Yancey to sue the two doctors individually for allegedly besmirching his reputation when they filed their grievance with the AAO.
According to American Medical Association policy, giving expert witness testimony is a form of medical practice and should be peer reviewed. AAO General Counsel Katherine Salazar-Poss said decisions like the one in Minnesota (other courts also have addressed this issue) affirm medical specialty societies' ability to enforce the ethical rules to which members consent and make sure doctors follow the same standards in front of a jury as they do with a patient.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More